Advancing cancer immunotherapy research

  • State-of the-art technology and systems for molecular and cellular analysis of immune response to cancer therapeutics
     
  • Scientific advice and technical support

CIO-IAL logo

CIO-TIGL is part of Cancer Immune Monitoring and Analysis Centers (CIMAC), an NCI-sponsored Immuno-Oncology Biomarkers Network